Infectious Respiratory Disease Diagnostics Market Size to Reach USD 15.41 Billion by 2034 at a 2.9% CAGR from 2026 to 2034

The infectious respiratory disease diagnostics market size was valued at USD 12.01 Billion in 2025 and is expected to reach USD 15.41 billion by 2034, growing at a CAGR of 2.9%. Infectious respiratory disease diagnostics involves testing methods used to detect viral and bacterial infections affecting the respiratory system across clinical and point-of-care settings. It supports early diagnosis, disease monitoring, and outbreak control through molecular, antigen, and multiplex testing technologies.

Key Statistics:

• Market Size (2025): USD 12.01 Billion
• Market Size (2034): USD 15.41 Billion
• CAGR (2026-2034): 2.9%
• Dominating Region: North America

Report Highlights:

• Rising incidence of respiratory infections is increasing demand for early and accurate diagnostics.
• Increasing aging population is driving higher diagnostic testing needs.
• High testing volume across laboratories and hospitals are driving kits & reagents market. This segment held largest market share with 54.95% share in 2025 and is expected to remain dominant over forecasted period.
• In 2025, the COVID-19 segment dominated the market with 29.9% revenue share owing to the constant surveillance and occasional outbreaks.
• Home testing / POCT segment is projected to grow at the fastest CAGR of 3.1% during the forecast period. This is mainly due to rising demand for convenient and rapid testing solutions
• North America dominated revenue with 43.72% revenue share because of strong healthcare infrastructure and high testing volumes.
• Asia Pacific infectious respiratory disease diagnostics market is projected to grow at the fastest CAGR of 3.5% during the forecast period, owing to rising population and increasing incidence of respiratory infections.
• Key companies include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, QIAGEN, and others.

What’s Included in Infectious Respiratory Disease Diagnostics Report?

The report presents a detailed overview of the market for infectious respiratory disease diagnostics based on product, disease type, and end user. It includes regional analysis, technology assessment, value chain evaluation, and competitive landscape.

What are Driving Factors and Emerging Trends of Infectious Respiratory Disease Diagnostics Market?

As per our analysis, the market is increasing due to rising infection rates and increasing aging population. The major factors that are responsible for the growth of the infectious respiratory disease diagnostics market are:

• Rising Incidence of Respiratory Infections: Increasing infection rates are driving demand for rapid and accurate diagnostic solutions across healthcare settings. In April 2026, Salaera introduced breath-based diagnostics for respiratory detection without the need for invasiveness.
• Growing Geriatric Population: The growing number of geriatrics susceptible to respiratory infections is contributing to an increase in testing. According to the WHO, the 60+ age group will be at 1.4 billion in 2030 and 2.1 billion in 2050 while the 80+ age group will stand at 426 Billion.
• Advancement in Home Diagnostics: Increased use of self-test kits is providing accessibility to users.

These trends align with the current trend toward increased emphasis on early diagnosis and decentralized testing.

Request a free sample copy or read the full market insights: Infectious Respiratory Disease Diagnostics Market Report

Which Key Segments are Driving Infectious Respiratory Disease Diagnostics Market?

By Product Analysis

The kits & reagents were the largest segment as the frequency of testing was very high.

By Disease Type Analysis

COVID-19 dominated the market, driven by ongoing surveillance and testing requirements.

By End User Analysis

Diagnostic labs dominated the market, driven by high testing capacity and centralized infrastructure.

Which is Dominating Region in Infectious Respiratory Disease Diagnostics Market?

North America: North America dominated in 2025 due to strong healthcare infrastructure and high adoption of molecular diagnostics. For instance, researchers from University of Maryland School of Medicine developed a method to improve early respiratory infection detection.

Asia Pacific: Asia Pacific is expected to grow at the fastest rate due to rising infection rates and expanding healthcare access. UNFPA states Asia Pacific 60+ population will reach 1.3 billion by 2050, with women at 53% (60+) and 60% (80+).

Where is Infectious Respiratory Disease Diagnostics Market Headed?

According to analysis, the market is moving toward steady expansion supported by growth in home diagnostics, AI-driven testing, and decentralized healthcare models.

What Infectious Respiratory Disease Diagnostics Market Report Reveals?

• What is the global market size, growth trend, and CAGR for infectious respiratory disease diagnostics through 2034?
• What are the factors driving the market growth?
• Who are the top companies, and what is their relative position in terms of competitive positioning?
• How are companies expanding point-of-care and home-based diagnostic solutions?
• How is adoption of AI and multiplex testing shaping competition in the infectious respiratory disease diagnostics market?
• What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
• Where do new opportunities arise in the infectious respiratory disease diagnostics market?

Who are Major Infectious Respiratory Disease Diagnostics Market Contributors?

According to our study, a few firms are leading in the global market. The following are some of the major market contributors:

• Abbott Laboratories
• Becton Dickinson and Company
• bioMérieux
• Cepheid
• Danaher Corporation
• Hologic Inc.
• QIAGEN
• QuidelOrtho Corporation
• Roche Diagnostics
• Seegene Inc.
• Siemens Healthineers
• Thermo Fisher Scientific

Market Segments Covered

By Product Outlook (Revenue, USD Billion, 2021-2034)

• Kits & Reagents
• Instruments
• Services

By Disease Type Outlook (Revenue, USD Billion, 2021-2034)

• COVID-19
• Influenza
• Tuberculosis
• RSV
• Pneumonia

By End User Outlook (Revenue, USD Billion, 2021-2034)

• Hospitals
• Diagnostic Labs
• Home Testing / POCT

By Regional Outlook (Revenue, USD Billion, 2021-2034)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherland
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Israel
  • Rest of Middle East & Africa